Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial
Sponsor: Australian and New Zealand College of Anaesthetists
Terminated
Not meeting recruitment timelines
Other Colonic Cancer trials with similar outcome
This PHASE3 trial investigates Colonic Cancer and Non Small Cell Lung Cancer and is currently terminated or withdrawn. Australian and New Zealand College of Anaesthetists leads this study, which shows 9 recorded versions since 2020 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
9 versions recorded-
Apr 2025 — Present [monthly]
Terminated PHASE3
Status: Recruiting → Terminated
-
Sep 2024 — Apr 2025 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Apr 2023 — Jul 2024 [monthly]
Recruiting PHASE3
-
Sep 2022 — Apr 2023 [monthly]
Recruiting PHASE3
▶ Show 4 earlier versions
-
Sep 2021 — Sep 2022 [monthly]
Recruiting PHASE3
-
Mar 2021 — Sep 2021 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Not Yet Recruiting PHASE3
-
Apr 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Australian and New Zealand College of Anaesthetists
- National Health and Medical Research Council, Australia
- Peter MacCallum Cancer Centre, Australia
- Victorian Comprehensive Cancer Centre
For direct contact, visit the study record on ClinicalTrials.gov .